Please login to the form below

Not currently logged in
Email:
Password:

Wellcome Trust director Sir Mark Walport named UK’s chief scientific adviser

Will provide scientific advice direct to Prime Minister David Cameron and the cabinet

The director of research charity the Wellcome Trust Sir Mark Walport has been appointed chief scientific adviser to the UK government.

Taking up his new post in April, 2013, Sir Mark will replace Sir John Beddington in providing advice directly to Prime Minister David Cameron and the cabinet concerning scientific issues.

“Science, engineering and technology have transformed the infrastructure of the modern world, and have a vital role to play at the heart of policy making,” said Sir Mark.

"They are critical both to economic recovery and growth, and to addressing many of the greatest challenges of our time, such as environmental change and the ageing population.”

With a background in immunology, Sir Mark will play a key role in the implementation of the £180m worth of life sciences reforms in the UK announced by Cameron at the end of 2011.

He will also work with ministers, the scientific community and the media to ensure that scientific methods, risk and uncertainty are understood by the public.

Sir Mark had been director of the Wellcome Trust since 2003, leading the body in its support of scientific and medical research.

This included studies into the human genome and human brain, infectious diseases such as malaria and MRSA, and chronic diseases such as diabetes and cancer.

The Trust's chair Sir Bill Castell is to lead the board of governors in the recruitment of a new director.

He said: "Mark has led the Wellcome Trust with great distinction over a decade of extraordinary achievement, and there is nobody in Britain better placed to ensure that science plays the central role it deserves to in public policy. British science will be stronger for his appointment.”

5th July 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics